Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Due to its unusual structural stability and resistance to degradation in acidic environments, BPC-157 has attracted attention in experimental models studying vascular repair, inflammatory modulation, and soft tissue regeneration
The precursor literature includes human pharmacokinetic work
BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
Available in 5mg lyophilized vials
Not everyone experiences these effects, and when they do occur they are generally short-lived
US$ 21.63
US$ 26.41
US$ 28.84
US$ 25.31
US$ 20.13
